cell lung cancer

Phase III TAISHAN-302 trial shows Tam-Peli significantly improves survival in relapsed small-cell lung cancer

Phase III MAVERICK trial supports brain MRI surveillance alone as standard of care for small-cell lung cancer

Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer